GlassScriptPhysician profile
David K Murdock
NPI 1942200910
$163,897.37
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $12K · 2021: $40K · 2022: $22K · 2023: $25K · 2024: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $1,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,762.50 |
| Food and Beverage | $1,638.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $93,182.25 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $42,460.61 | 2019-2024 | Jardiance |
| Regeneron Pharmaceuticals, INC. | $10,398.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $7,512.94 | 2019-2020 | |
| Amgen INC. | $6,343.22 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $1,500.00 | 2020 | |
| Novo Nordisk INC | $380.49 | 2019-2024 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $350.66 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $250.00 | 2019-2022 | |
| Pfizer INC. | $226.54 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $208.38 | 2019-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $203.84 | 2019 | |
| Medtronic, INC. | $180.45 | 2024 | Endurant Iis |
| United Therapeutics Corporation | $125.00 | 2023 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Opsumit, Uptravi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $115.81 | 2022 | |
| Inari Medical, INC. | $98.11 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $88.88 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.90 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $66.62 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.